Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms
MSK Injury Assessment Imaging System: Feasibility and Data Acquisition for Algorithm Development and Testing
The Accuro XV is a cart-based, bedside ultrasound instrument that incorporates new signal processing-based technologies for enhanced bone and soft-tissue imaging.
Patients presenting to the Study Setting (e.g., Emergency Departments, urgent care centers, orthopedic clinics, radiology departments, and other clinical environments with access to standard-of-care (SOC) imaging with a suspected distal extremity injury (wrist, forearm, ankle, or lower leg) who have undergone SOC imaging during their clinical evaluation, will be enrolled for additional extremity imaging with the Accuro XV.
In this feasibility study, investigators will assess the safety of Accuro XV by review of any adverse events (AEs) and by comparing the comfort level of patients during Accuro XV image capture and standard-of-care imaging. Investigators will retrospectively assess image quality by reviewing all images captured to ensure the image is clear of artifact and other visual imperfections. The de-identified imaging data will then be used for algorithm development and testing. This data will help to verify plans for future study protocols and help to ensure the device is optimized for its clinical use prior to further clinical studies. The results will also be used as an input to RIVANNA's usability and human factors engineering process per IEC 60601-1-6 as recognized by FDA.
The Accuro XV is investigational in this study and is not intended to guide clinical decision-making.
Visão geral do estudo
Status
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Delphine Le Roux, PhD
- Número de telefone: 804-514-0589
- E-mail: dleroux@rivannamedical.com
Locais de estudo
-
-
California
-
San Francisco, California, Estados Unidos, 94143
- Recrutamento
- The University of California San Francisco
-
Contato:
- Elizabeth Butrick
- Número de telefone: 4156016399
- E-mail: Elizabeth.butrick@ucsf.edu
-
Investigador principal:
- Aaron Kornblith, MD
-
-
Colorado
-
Denver, Colorado, Estados Unidos, 80204
- Recrutamento
- The University of Colorado Denver
-
Contato:
- Carolynn Lyle
- Número de telefone: 3036025235
- E-mail: Carol.Lyle@dhha.org
-
Investigador principal:
- Matthew Riscinti, MD
-
-
Connecticut
-
New Haven, Connecticut, Estados Unidos, 06510
- Recrutamento
- Yale University
-
Contato:
- Ryan Denkewicz, MD
- Número de telefone: 4013396076
- E-mail: ryan.denkewicz@yale.edu
-
Investigador principal:
- Cristiana Baloescu, MD
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60612
- Recrutamento
- Rush University Medical Center
-
Investigador principal:
- Michael Gottlieb, MD
-
Contato:
- Michael Gottlieb, MD
- Número de telefone: (312) 952-6615
- E-mail: Michael_A_Gottlieb@rush.edu
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Recrutamento
- Thomas Jefferson University Hospital
-
Contato:
- Nicole Renzi
- Número de telefone: 215-955-2471
- E-mail: Nicole.renzi@jefferson.edu
-
Investigador principal:
- Jason Fields, MD
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75390
- Recrutamento
- The University of Texas Southwestern
-
Contato:
- Riley Martin
- Número de telefone: 2146482147
- E-mail: riley.martin@utsouthwestern.edu
-
Investigador principal:
- Philip Jarrett, MD
-
El Paso, Texas, Estados Unidos, 79905
- Recrutamento
- Texas Tech University Health Sciences Center
-
Contato:
- Diluma Kariyawasam
- Número de telefone: 9152154649
- E-mail: dkariyaw@ttuhsc.edu
-
Investigador principal:
- Kara Samsel, MD
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84112
- Recrutamento
- The University of Utah
-
Contato:
- Marina Griffith
- Número de telefone: 8015298668
- E-mail: marina.griffith@hsc.utah.edu
-
Investigador principal:
- Christopher Kelly, MD
-
-
Virginia
-
Charlottesville, Virginia, Estados Unidos, 22904
- Recrutamento
- The University of Virginia
-
Contato:
- Ashley Simpson
- Número de telefone: 4349242897
- E-mail: APS2H@uvahealth.org
-
Investigador principal:
- Christopher Thom, MD
-
Richmond, Virginia, Estados Unidos, 23298
- Recrutamento
- Virginia Commonwealth University
-
Contato:
- Samuel Chun
- Número de telefone: 8049555067
- E-mail: Samuel.Chun@vcuhealth.org
-
Investigador principal:
- Jordan Tozer
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Sites are currently on two different protocol Revisions.
Inclusion Criteria
- Age greater than or equal to 5 years.
- The patient is presenting for distal limb injury of the wrist, forearm, ankle, or lower leg.
- The patient is scheduled to receive an X-ray that includes a view of the ankle, lower leg, wrist, and/or forearm or any patient that received an X-ray accessible by the study team for the studied anatomy in the past 48 hours.
- English and/or Spanish speaking.
Exclusion Criteria
- An open fracture, grossly open wound, or severe angulation of the limb is present.
- Patients for whom the site investigator feels that study participation could prohibit or impair ongoing medical care.
- Known allergy to ultrasound couplants.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Accuro XV Imaging
Participants with a distal extremity injury who have undergone standard-of-care imaging will receive additional imaging with the Accuro XV ultrasound imaging system. Accuro XV imaging will be performed after completion of standard-of-care clinical imaging and will not be used for clinical decision-making or patient management. Imaging data collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms. |
The Accuro XV Ultrasound Imaging System is a cart-based ultrasound imaging device designed to acquire volumetric images of bone and soft tissue anatomy of the distal extremities. In this study, participants will undergo additional Accuro XV imaging following standard-of-care imaging for a distal extremity injury. The imaging procedure includes acquisition of multiple views of the injured anatomy using ultrasound technology and advanced image-processing methods to generate three-dimensional representations of bone and soft tissue structures. Images collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms. Accuro XV imaging results will not be used for clinical decision-making. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Accuro XV Image Quality Assessment
Prazo: From Accuro XV image acquisition through completion of retrospective image-quality assessment, up to 48 months.
|
Retrospective assessment of acquired Accuro XV images for artifacts and other visual imperfections to evaluate image quality and suitability for subsequent analysis and algorithm development. |
From Accuro XV image acquisition through completion of retrospective image-quality assessment, up to 48 months.
|
|
Feasibility of Accuro XV Imaging Acquisition
Prazo: During and immediately after Accuro XV imaging on the day of enrollment.
|
Successful acquisition of Accuro XV images of the target distal extremity anatomy according to study procedures; site PIs, AIs, and other Accuro XV users will be queried on how Accuro XV fits into their clinical workflow in terms of usability, maneuverablity, reliability and more. Surveys to be developed. |
During and immediately after Accuro XV imaging on the day of enrollment.
|
|
Participant Comfort During Imaging
Prazo: Immediately after Accuro XV imaging on the day of enrollment.
|
Participant-reported comfort and pain scores associated with Accuro XV imaging collected through the participant questionnaire. Participants completed a questionnaire assessing pain associated with both standard-of-care imaging and Accuro XV scanning. Specifically, participants were asked to rate their pain (1) before standard-of-care imaging, (2) during standard-of-care imaging, (3) before Accuro XV scans, and (4) during Accuro XV scans. Pain was measured using an 11-point Likert-type scale ranging from 0 ("none") to 10 ("severe"), with higher scores indicating greater pain. |
Immediately after Accuro XV imaging on the day of enrollment.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Likert-Type Scale Participant-reported Imaging Modality Preference
Prazo: Immediately after Accuro XV imaging on the day of enrollment.
|
Participant-reported preference between Accuro XV imaging and standard-of-care imaging modalities. Participants completed a questionnaire assessing satisfaction with both standard-of-care imaging and Accuro XV scanning. Participants were asked to rate their satisfaction with each imaging modality on an 11-point Likert-type scale ranging from 0 ("not satisfied at all") to 10 ("very satisfied"), with higher scores indicating greater satisfaction. In addition, participants were asked to indicate their preferred imaging modality by selecting either Accuro XV, standard-of-care imaging, or no preference. |
Immediately after Accuro XV imaging on the day of enrollment.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Pro00075277
- 75A50121C00035 (Número de outro subsídio/financiamento: Biomedical Advanced Research Development Authority (BARDA))
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .